Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2107-0180
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling ; volume:48 ; number:1 ; day:14 ; month:12 ; year:2022 ; pages:119 ; date:1.2023
European journal of drug metabolism and pharmacokinetics ; 48, Heft 1 (14.12.2022), 119, 1.2023
- Creator
-
Kinvig, Hannah
Cottura, Nicolas
Lloyd, Andrew
Frivold, Collrane
Mistilis, Jessica
Jarrahian, Courtney
Siccardi, Marco
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13318-022-00811-7
- URN
-
urn:nbn:de:101:1-2023031522082350995979
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kinvig, Hannah
- Cottura, Nicolas
- Lloyd, Andrew
- Frivold, Collrane
- Mistilis, Jessica
- Jarrahian, Courtney
- Siccardi, Marco
- SpringerLink (Online service)
Other Objects (12)
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions